Long-term remissions with weekly chlorambucil therapy in patients with intermediate-risk chronic lymphocytic leukaemia [3]

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1193-

  Manoharan, A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Chlorambucil; Chronic lymphocytic leukaemia; Maintenance therapy

Indexed keywords

CHLORAMBUCIL; FLUDARABINE;

ADULT; AGED; CANCER GROWTH; CANCER REGRESSION; CANCER STAGING; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG INDICATION; DRUG RESPONSE; FEMALE; HEART FAILURE; HUMAN; LETTER; LONG TERM CARE; LYMPHOCYTOSIS; MAINTENANCE THERAPY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRAFFIC ACCIDENT;

EID: 0036046117     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.36623.x     Document Type: Letter

References (3)

1. National Cancer Institute - Sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment
2. Management of chronic lymphocytic leukaemia
3. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia